However, many studies found that CHI3L1 alone may not be as effective as other single biomarkers like CK-18 or sSiglec-7 in diagnosing NAFLD-related fibrosis. This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatotic liver disease.